Medline Inc. (MDLN) Stock Analysis
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $35.67, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%).
Medline is the largest provider of medical-surgical products and supply chain solutions, offering approximately 335,000 products across Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute settings. In 2025, 69% of... Read more
Hold if already holding. Not a fresh buy at $35.67, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Mixed signals. Hold existing position. Score 5.8/10, moderate confidence.
Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news boost analyst 0.60, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: moderate.
Recent Developments — Medline Inc.
Latest news
- Tigress Financial raises Medline stock price target on AI supply chain shift By Investing.com - Investing.com South Afri — Investing.com South Africa positive
- Tigress Financial raises Medline stock price target on AI supply chain shift - Investing.com Canada — Investing.com Canada positive
- Medline (NASDAQ:MDLN) Trading Down 10.5% - Here's Why - MarketBeat — MarketBeat negative
- Medline Stock Alert (MDLN) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of Medline Investo — ACCESS Newswire negative
- Medonde: Medline Stock (MDLN) Opinions on Q1 Earnings Release - Quiver Quantitative — Quiver Quantitative neutral
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHCustomerVizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs)69%10-K Item 1A: '69% of consolidated net sales ... under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.'
- HIGHCustomerPrime Vendor agreements63%10-K Item 1A: 'Our active Prime Vendor agreements as of December 31, 2025 generated approximately 63.4% ($18.0 billion) of net sales'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $35.67, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Mixed signals. Hold existing position. Target $46.60 (+30.6%), stop $34.64 (−3.0%), A.R:R 2.8:1. Score 5.8/10, moderate confidence.
Take-profit target: $46.60 (+30.4% upside). Target $46.60 (+30.6%), stop $34.64 (−3.0%), A.R:R 2.8:1. Stop-loss: $34.64.
Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3).
Medline Inc. trades at a P/E of 31.7 (forward 21.8). TrendMatrix value score: 7.1/10. Verdict: Hold.
34 analysts cover MDLN with a consensus score of 4.1/5. Average price target: $52.
What does Medline Inc. do?Medline is the largest provider of medical-surgical products and supply chain solutions, offering approximately 335,000...
Medline is the largest provider of medical-surgical products and supply chain solutions, offering approximately 335,000 products across Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute settings. In 2025, 69% of consolidated net sales came through member hospitals under GPO contracts with Vizient, HealthTrust, and Premier; Prime Vendor agreements generated 63.4% ($18.0B) of net sales.